Business
FTC Settles Insulin Price Manipulation Case with CVS Caremark
The FTC has settled a lawsuit against CVS Caremark, alleging that the company artificially inflated insulin prices and impeded patient access. The settlement aims to address these practices.
Coverage timeline — 1 article
STAT News
The FTC settled a lawsuit against CVS Caremark over allegations that the company artificially inflated the price of insulin and impeded access to the diabetes treatment.
2026-07-14 20:55 UTC